"The Report Diabetes &
Obesity Drug Development Pipeline Review, 2016 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
The diabetes and obesity disease
cluster is currently dominated by therapeutics indicated for type 1
diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the
majority of the pipeline, in terms of both quantity and quality of
products, is attributable to these indications. While products
indicated for obesity do not currently have a large market presence,
there are a large number of these products in the pipeline, with the
majority in early stages of development.
View Report @
http://www.marketresearchreports.biz/analysis/877732
The combined therapy area of
diabetes and obesity presents a strong pipeline, accounting for a
large proportion of the overall metabolic disorders therapy area. The
majority of products are small molecules and biologics, which
reflects the overall pharmacotherapeutic market trend.
An increasing pipeline presence
for obesity-indicated products and overwhelming global media interest
highlight the relevance of this indication and its future potential
global revenues. However, the number of pharmacotherapeutic products
for obesity is dwarfed by diabetes-indicated products. Given the
status of obesity as a risk factor for T2DM, it is likely that the
T2DM pipeline will continue to grow with the rising obesity
incidence.
Get Sample Copy Of This Report
@
Scope
- Which companies are the most active within the pipeline for diabetes and obesity?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
- What are the most important R&D milestones and data publications to have occurred in this disease area?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication.
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each.
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these.
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.
Table of Contents
List of Tables
List of Figures
Diabetes and Obesity Report
Coverage
Type 1 Diabetes (Juvenile
Diabetes) Overview
Type 2 Diabetes Overview
Obesity Overview
Therapeutics Development by Stage
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Therapeutics under Development by
Companies
Type 1 Diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Therapeutics under Investigation
by Universities/Institutes
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Pipeline Products Glance
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Products under Development by
Companies
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Products under Investigation by
Universities/Institutes
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Companies Involved in Therapeutics
Development
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Therapeutics Assessment
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Dormant Projects
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Discontinued Products
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
Product Development Milestones
Type 1 diabetes (Juvenile
Diabetes)
Type 2 Diabetes
Obesity
About Us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment